DOMINO-AD: Donepezil and Memantine in Moderate to Severe Alzheimer's Disease

Clinical trial data from the DOMINO-AD study investigating the effects of Donepezil and Memantine on patients with moderate to severe Alzheimer's Disease. The dataset was published on the paperswithcode platform by author Robert Howard. The specific data format, size, and temporal coverage are not detailed in the available metadata.

Use Cases

• Analyze treatment efficacy for moderate to severe Alzheimer's Disease (inferred from domain, verify after download)
• Compare patient outcomes between drug combination therapies (inferred from domain, verify after download)
• Build predictive models for dementia progression (inferred from domain, verify after download)

Strengths

• Published on the paperswithcode platform.
• Associated with a named author, Robert Howard.

Limitations

• Metadata is minimal; actual content requires verification after download.
• Row count, column definitions, and file formats are unknown.
• License is listed as 'closed', which may restrict usage.

Provenance

Source

paperswithcode